JCCG 活動情報 －論文投稿 2015 年―
（主）
：主論文

神経芽腫委員会
Fumino S, Kimura K, Iehara T, Nishimura M, Nakamura S, Souzaki R, Nishie A, Taguchi T, Hosoi H, Tajiri
T. Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in WesternJapan. J Pediatr Surg. 50:2102. 2015. PMID:26388125
中川原章：COG and JCCG

JCCG と COG 小児血液・がん研究の将来へ向けたグローバルな挑戦. 日本小児血液・がん学会雑誌. 52:359. 2015.

腎腫瘍委員会（主）Kaneko Y, Okita H, Haruta M, Arai Y, Oue T, Tanaka Y, Horie, H, Hinotsu, S, Koshinaga, T, Yoneda,A, Ohtsuka, Y, Taguchi, T, Fukuzawa, M. A high incidence of WT1 abnormality in bilateral Wilms tumours
in Japan, and the penetrance rates in children with WT1 germline mutation. Br J Cancer. 112:1121. 2015.
PMID:25688735
Oue T, Fukuzawa M, Koshinaga T, Okita H, Nozaki M, Chin M, Kaneko Y, Tanaka Y, Haruta M, Tsuchiya
K, Kuwajima S, Takimoto T. Management of pediatric renal tumor: Past and future trials of the JapanWilms Tumor Study Group. Pediatrics international. Pediatr Int. 57:828. 2015. PMID:26267611

肝腫瘍委員会Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, Kurihara
S, Ueda Y, Onitake Y. Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experienceof the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials. J Pediatr Surg. 50:2098. 2015.
PMID:26388131
Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng Y, Aronson D,Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, von Schweinitz D,Schmid I, Watanabe K, Derosa M, Meyers R. The Children's Hepatic tumors International Collaboration(CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes aresearch model. Eur J Cancer. 52:92. 2015. PMID:26655560

リンパ腫委員会
Kobayashi R, Sunami S, Mitsui T, Nakazawa A, Koga Y, Mori T, Tanaka F, Ueyama J, Osumi T, Fukano R,Ohki K, Sekimizu M, Mori T; Lymphoma Committee; Japanese Pediatric Leukemia/Lymphoma Study
Group. Treatment of pediatric lymphoma in Japan: Current status and plans for the future. Pediatr Int.
57:523. 2015. PMID:26096060
Sekimizu M, Mori T, Kikuchi A, Mitsui T, Sunami S, Kobayashi R, Fujita N, Inada H, Takimoto T, Saito
AM, Watanabe T, Fujimoto J, Nakazawa A, Ohshima K, Horibe K, Tsurusawa M; Lymphoma Committeeof the Japanese Pediatric Leukemia/Lymphoma Study Group. Prognostic impact of cytogenetic
abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from theJapanese Pediatric Leukemia/Lymphoma Study Group (JPLSG). Pediatr Blood Cancer. 62:1294. 2015.
PMID:25790170

AML 委員会
Jo A, Mitani S, Shiba N, Hayashi Y, Hara Y, Takahashi H, Tsukimoto I, Tawa A, Horibe K, Tomizawa D,Taga T, Adachi S, Yoshida T, Ichikawa H. High expression of EVI1 and MEL1 is a compelling poor
prognostic marker of pediatric AML. Leukemia. 29:1076. 2015. PMID:25567132
Sano H, Ohki K, Park MJ, Shiba N, Hara Y, Sotomatsu M, Tomizawa D, Taga T, Kiyokawa N, Tawa A,Horibe K, Adachi S, Hayashi Y. CSF3R and CALR mutations in paediatric myeloid disorders and theassociation of CSF3R mutations with translocations. Br J Haematol. 170:391. 2015. PMID:25858548
Tomizawa D, Watanabe T, Hanada R, Horibe K, Horikoshi Y, Iwamoto S, Kinoshita A, Moritake H,Nakayama H, Shimada A, Taga T, Takahashi H, Tawa A, Terui K, Hori H, Kawano Y, Kikuta A, ManabeA, Adachi S. Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.
Int J Hematol. 102:318. 2015. PMID:26126642
Inaba H, Zhou Y, Abla O, Adachi S, Auvrignon A, Beverloo HB, de Bont E, Chang TT, Creutzig U, Dworzak
M, Elitzur S, Fynn A, Forestier E, Hasle H, Liang DC, Lee V, Locatelli F, Masetti R, De Moerloose B,Reinhardt D, Rodriguez L, Van Roy N, Shen S, Taga T, Tomizawa D, Yeoh AE, Zimmermann M, Raimondi
SC. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: aretrospective international study. Blood. 126:1575. 2015. PMID:26215111
Tokumasu M, Murata C, Shimada A, Ohki K, Hayashi Y, Saito AM, Fujimoto J, Horibe K, Nagao M, ItohH, Kamikubo Y, Nakayama H, Kinoshita A, Tomizawa D, Taga T, Tawa A, Tanaka S, Heike T, Adachi S.

Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese PediatricLeukemia/Lymphoma Study Group AML-05 trial. Leukemia. 29:2438. 2015. PMID:25975190

HLH/LCH 委員会
森本 哲, 塩田曜子, 工藤寿子, 今村俊彦. ランゲルハンス細胞組織球症に対する化学療法の適応と有効性. 血液内科. 71:535. 2015.

ALL 委員会（主）Manabe A, Kawasaki H, Shimada H, Kato I, Kodama Y, Sato A, Matsumoto K, Kato K, Yabe H, Kudo
K, Kato M, Saito T, Saito A M., Tsurusawa M, Horibe K. Imatinib use immediately before stem celltransplantation in children with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Resultsfrom Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph+ALL04. Cancer Med.
4:682. 2015. PMID:25641907（主）Koh K, Tomizawa D, Moriya Saito A, Watanabe T, Miyamura T, Hirayama M, Takahashi Y, Ogawa
A, Kato K, Sugita K, Sato T, Deguchi T, Hayashi Y, Takita J, Takeshita Y, Tsurusawa M, Horibe K, MizutaniS, Ishii E. Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL generearrangement-positive acute lymphoblastic leukemia. Leukemia. 29:290. 2015. PMID:24888273
Aoki Y, Watanabe T, Saito Y, Kuroki Y, Hijikata A, Takagi M, Tomizawa D, Eguchi M, Eguchi-Ishimae M,Kaneko A, Ono R, Sato K, Suzuki N, Fujiki S, Koh K, Ishii E, Shultz LD, Ohara O, Mizutani S, Ishikawa F.
Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acutelymphoblastic leukemia. Blood. 125:967. 2015. PMID:25538041
Hatanaka M, Miyamura T, Koh K, Taga T, Tawa A, Hasegawa D, Kajihara R, Adachi S, Ishii E, Tomizawa
D.

Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of theJapanese Pediatric Leukemia/Lymphoma Study Group. Int J Hematol. 102:697. 2015. PMID:26520649

名古屋データセンター
中村健一、柴田大朗、福田治彦、中村慎一郎、齋藤明子、青谷恵利子、関根信幸、本田純久. がんの多施設共同研究グループによる共通ガイドライン（モニタリング・監査・有害事象報告） . 薬理と治療.
43(Suppl.1):s36. 2015